Viewing Study NCT07010302


Ignite Creation Date: 2025-12-25 @ 3:43 AM
Ignite Modification Date: 2025-12-26 @ 2:29 AM
Study NCT ID: NCT07010302
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-06-11
First Post: 2025-05-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD
Sponsor: Massachusetts General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module